Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
From an evidence quality standpoint, Dihexa sits below Semax and Selank, even though all three are operating outside FDA approval
This bypasses digestion entirely, allowing the peptide to enter circulation and reach tissues throughout the body
PMID: 39325560 Sikiric P et al
First, phase II clinical trials evaluating MOTS-c in type 2 diabetes and sarcopenia are in development, and their results will provide the first randomized controlled evidence in humans to define therapeutic doses with statistical rigor
US$ 20.44
US$ 23.49
US$ 23.78
US$ 29.51
US$ 21.32
US$ 29.71
